3.65
Finanzdaten der Prime Medicine Inc-Aktie (PRME)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.59%
0.838
|
1.225 | 1.115 | 1.454 | 2.183 |
|
|
10.42%
49.45
|
55.20 | 54.49 | 53.85 | 46.41 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
10.42%
49.45
|
55.20 | 54.49 | 53.85 | 46.41 |
| Operating Income/Loss |
9.94%
-48.61
|
-53.97 | -53.38 | -52.39 | -44.22 |
| Nonoperating Income/Loss |
25.42%
2.529
|
3.391 | 0.786 | 0.502 | 1.946 |
| Income/Loss From Continuing Operations Before Tax |
31.59%
0.838
|
1.225 | -52.59 | -51.89 | 2.183 |
| Income/Loss From Continuing Operations After Tax |
8.90%
-46.08
|
-50.58 | -52.59 | -51.89 | -42.28 |
|
|
8.90%
-46.08
|
-50.58 | -52.59 | -51.89 | -42.28 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.07%
9.5138
|
160.50 | 129.19 | 130.88 | 4.108 |
| Diluted Average Shares |
94.07%
9.5138
|
160.50 | 129.19 | 130.88 | 4.108 |
| Basic Earnings Per Share |
25.00%
-0.24
|
-0.32 | -0.41 | -0.40 | -0.31 |
| Diluted Earnings Per Share |
25.00%
-0.24
|
-0.32 | -0.41 | -0.40 | -0.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):